Abstract
A key pathological hallmark of Alzheimer's disease (AD) is the deposition of b -amyloid in the brain. There is a strong association between brain amyloid burden and the risk of developing AD-like pathology. Imaging using markers of b -amyloid combined with Positron Emission Tomography (PET) allows a semi-quantitative in vivo assessment of A b depostion in the subject brains. However, this approach is invasive, costly and restricted to specialised centres. Candidate blood protein biomarkers that predicted global neocortical brain amyloid load have been recently identified (our group and Burnham et al.
Original language | Undefined/Unknown |
---|---|
Article number | P1-166 |
Pages (from-to) | P360-P361 |
Journal | Alzheimer's & dementia : the journal of the Alzheimer's Association |
Volume | 10 |
Issue number | 4 Supplement |
DOIs | |
Publication status | Published - 1 Jul 2014 |